Hard capsules - 1 mg

Ketofex contains the active substance ketotifen fumarate, which is a medicine used for the prevention and treatment of allergic symptoms.

It is indicated in:

• allergic rhinitisand allergic skindiseasesin terms ofsymptomatictreatment, whentreatment withoralnon-sedatingantihistamines (antihistamines which do not cause drowsiness), and local use of antihistaminesand glucocorticoids, (cortisone preparations) isnot appropriate;
• long-term preventionofasthmatic symptomsin combinationwith other anti-inflammatory drugsin allergicpolysymptomatics (e.g. patients with allergic bronchial asthma and hay fever).

Tablets - 15 mg

Tablets – 10 mg

Tablets - 10 mg

Lorade contains the active substance loratadine, which is part of a group of medicines called antihistamines.

Lorade is used to treat symptoms of allergic rhinitis (e.g. hay fever) and for chronic idiopathic urticaria (hives of unknown origin).

Syrup - 5 mg/5 ml

Sugar coated tablets - 50 mg

Mebhydrolin is a substance that is part of the group of antihistamines. The antihistamines reduce or inhibit the main actions of histamine in the organism through the reversible and competitive block of the histamine receptors; they do not disactivate histamine or do not prevent its synthesis or release. Mebhidroline presents antimuscarinic, serotonine antagonist properties and local anaesthetic effects. It is used for the symptomatic relief of hypersensitivity reactions, including urticaria and angioedema, rhinitis and conjunctivitis. It is considered as ineffective in asthma.

Mebhidroline sugar-coated tablet 50 mg is indicated in:

• hay fever;
• vasomotor rhinitis;
• bronchial asthma with an allergic origin;
• urticaria;
• exanthema by drugs;
• itching;
• eczema;
• allergic dermatitis and conjunctivitis;
• insect bites;
• Quincke oedema,
• food idiosyncrasias.

Chewable tablets - 5 mg

Film coated tablets - 10 mg

Syrup - 250 mg / 5 ml

Syrup - 100 mg / 5 ml

Sugar coated tablets - 25 mg

Promethazine is a phenothiazine derivative, which decreases or eliminates the main histamine actions by competing with histamine or reversibly blocking histamine receptors in tissues. Promethazine does not deactivate histamine, and does not prevent its secretion. H₁ receptors are responsible for blood vessel dilation, increase of capillary permeability, itching and, up to an extent, for bronchial and gastrointestinal tract smooth muscle contractions. Promethazine has also antimuscarinic properties, antagonizing effects of adrenaline and serotonin and local anesthetic effects.

Prometazine 25 mg sugar-coated tablets are indicated in:

• temporary relief of rhinorrhea and sneezing associated with flu;
• symptomatic relief of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis;
• relief of symptoms such as pruritus of allergic and non-allergic origin;
• treatment of mild, uncomplicated skin manifestations of urticaria and angioedema;
• alleviation of allergic reactions from blood or plasma transfusions;
• treatment of dermographism;
• ancillary treatment in anaphylactic reactions;
• preoperative and postoperative sedation;
• prevention and management of nausea and vomiting associated with certain types of anaesthesia and surgical procedures;
• adjuvant treatment to analgesics for control of postoperative pain;
• facilitation of sleep;
• prevention and treatment of motion sickness (travelling by automobile, plane, ship).

Solution for injection - 50 mg / 2 ml

Promethazine is a phenothiazine derivative, which decreases or eliminates the main histamine actions by competing with histamine or reversibly blocking histamine receptors in tissues. Promethazine does not deactivate histamine, and does not prevent its secretion. H₁ receptors are responsible for blood vessel dilation, increase of capillary permeability, itching and, up to an extent, for bronchial and gastrointestinal tract smooth muscle contractions. Promethazine has also antimuscarinic properties, antagonizing effects of adrenaline and serotonin and local anesthetic effects.

Prometazine 50 mg / 2 ml solution for injection is indicated:

By intramuscular injection:

• in allergy;
• in preoperative sedation;
• in sedation during labor;

By intravenous injection:

• in allergy

as an adjuvant agent in anaesthesia and analgesia in order to reduce the dose of pethidine or other narcotic analgesics, especially in several specific surgical procedures (for example: repeated bronchoscopy, surgical ophthalmologic intervention).

Nasal spray solution - 0.5 mg / ml

Nasal spray solution - 0.25 mg / ml

Nasal drops, solution - 0.9 %